Antibiotic Exposure in the First Year of Life and the Risk of Attention-Deficit/Hyperactivity Disorder: A Population-based Cohort Study.

Abstract

Early childhood antibiotic exposure induces changes in gut microbiota reportedly associated with the development of Attention-Deficit/Hyperactivity Disorder (ADHD). We conducted a population-based cohort study to examine the association between antibiotic use in the first year of life and ADHD risk. We included children born in the Manitoba, Canada between 1998 and 2017. Exposure was defined as having filled one or more antibiotic prescriptions during the first year of life. ADHD diagnosis was identified in hospital abstracts, physician visits or drug dispensations. Risk of developing ADHD was estimated using Cox proportional hazards regression in a high dimensional propensity score-matched cohort (n= 69,738) and a sibling cohort (n= 67,671). ADHD risk was not associated with antibiotic exposure in the matched-cohort (hazard ratio = 1.02, 95% confidence interval: 0.97, 1.08 and in the sibling cohort (hazard ratio = 0.96, 95% confidence interval: 0.89, 1.03). In secondary analyses of the matched cohort, ADHD risk increase was observed in those exposed to 4 or more antibiotic courses or a duration longer than 3 weeks. These associations were not observed in the sibling cohort. We concluded that antibiotic exposure in the first year of life does not pose an ADHD risk on a population level.